Product logins

Find logins to all Clarivate products below.


René Böttcher

Associate Director for Discovery and Translational Science Consulting

René acts as Associate Director for Discovery and Translational Science Consulting at Clarivate. His team leverages network biology and machine learning to advance pharma and biotech customers’ research projects across a broad spectrum of areas, including target and biomarker identification, patient stratification and drug repositioning.

René has more than 10 years of experience as a computational biologist in both industry and academia. Through working in various fields including cancer biology, cellular signaling, molecular virology and network biology, René gathered a deep understanding of data processing (ETL), analyses, visualization and interpretation using a variety of molecular assay platforms.

René holds a PhD in Bioinformatics from Erasmus University Rotterdam (The Netherlands) and completed this Bachelors and Masters in Biosystems technology / Bioinformatics at the Technical University of Applied Sciences Wildau (Germany).

Latest news

Partner news June 25, 2026
LibTech Insights and Clarivate Announce “AI Essentials for Academic Libraries: Beyond the Basics”

Following the success of last year’s program, Clarivate and Choice team up once again to explore AI literacy topics in a three-part course June 25, 2026, Chicago, IL – Choice…

Partner news
News June 25, 2026
Clarivate and Healthcare Executive Unveil the 2026 Top 100 Most Innovative Chinese Pharmaceutical Companies

New ranking highlights the growing global influence of Mainland China’s pharmaceutical innovators London, U.K. June 25, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, and Healthcare Executive,…

News June 23, 2026
Clarivate Releases 2025 Sustainability Report

New report highlights progress against goals and a decline in total carbon emissions London, U.K. June 23 2026 — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence,…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.